MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 57 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,722,650 | -30.1% | 4,535,000 | 0.0% | 0.34% | -19.5% |
| Q2 2023 | $31,064,750 | -7.8% | 4,535,000 | +4.9% | 0.42% | -15.6% |
| Q1 2023 | $33,691,750 | +2.4% | 4,325,000 | 0.0% | 0.50% | +1.4% |
| Q4 2022 | $32,913,250 | +19.8% | 4,325,000 | +28.6% | 0.49% | -3.1% |
| Q3 2022 | $27,478,000 | -14.2% | 3,363,333 | +1.6% | 0.51% | -19.7% |
| Q2 2022 | $32,023,000 | -31.0% | 3,311,536 | +0.0% | 0.63% | -25.4% |
| Q1 2022 | $46,426,000 | -31.3% | 3,311,434 | 0.0% | 0.85% | -26.3% |
| Q4 2021 | $67,619,000 | +10.8% | 3,311,434 | 0.0% | 1.15% | +20.1% |
| Q3 2021 | $61,003,000 | -1.9% | 3,311,434 | 0.0% | 0.96% | -11.4% |
| Q2 2021 | $62,153,000 | – | 3,311,434 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $11,204,439 | 7.40% |
| NEA Management Company, LLC | 7,692,298 | $58,538,388 | 3.29% |
| Cormorant Asset Management, LP | 2,893,717 | $22,021 | 1.47% |
| Alphabet Inc. | 1,464,015 | $11,141,154 | 0.65% |
| Avoro Capital Advisors LLC | 4,325,000 | $32,913,250 | 0.49% |
| Casdin Capital, LLC | 510,882 | $3,887,812 | 0.30% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,242,893 | 0.19% |
| Virtus Investment Advisers, Inc. | 12,638 | $96,175 | 0.06% |
| Woodline Partners LP | 511,351 | $3,891,381 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $214,541 | 0.04% |